Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01949506 · ClinicalTrials.gov registry record · NA

(SBRT) and (ART) for Pulmonary Metastases From Soft Tissue Sarcomas

A NA study of Sarcoma,Soft Tissue and Stage IV Adult Soft Tissue Sarcoma, sponsored by Medical College of Wisconsin.

Completed
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT01949506: Completed NA study of Sarcoma,Soft Tissue and Stage IV Adult Soft Tissue Sarcoma, sponsored by Medical College of Wisconsin.

NCT01949506 is a NA study of Sarcoma,Soft Tissue and Stage IV Adult Soft Tissue Sarcoma that has completed, run by Medical College of Wisconsin. The registered enrollment target is 9 participants, below the 77-participant average among 12 other Sarcoma,Soft Tissue trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01949506, a NA study of Sarcoma,Soft Tissue and Stage IV Adult Soft Tissue Sarcoma, has completed, sponsored by Medical College of Wisconsin.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

This is a prospective study to document the local control rates with SBRT specifically for pulmonary metastases from soft tissue sarcoma. This study will prospectively document acute and late toxicity, quality of life (QoL), tumor control, and survival.

Primary Outcome

This measure (number of adverse events of grade ≥ 3 by Common Terminology Criteria for Adverse Events (CTCAE) criteria) will provide information regarding the acute toxicity of SBRT for \< 5 pulmonary metastases from soft tissue sarcoma..The CTCAE criteria provide a standardized description of adverse events including guidelines for grading severity. The guidelines can be viewed at: https://ctep.cancer.gov/protocoldevelopment/electronic\_applications/ctc.htm.

Conditions Studied

Sarcoma,Soft Tissue Stage IV Adult Soft Tissue Sarcoma

Interventions

  • RADIATION SBRT

Study Locations (1)

Wisconsin

  • Froedtert Hospital and Medical College of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2013-09-24
Est. Completion 2019-10-04
Phase NA
Medical College of Wisconsin

447 total trials

What the finished NCT01949506 record still lists

NCT01949506 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 77-participant average among 12 other Sarcoma,Soft Tissue trials with a reported enrollment target (88% lower).

The record links to 2 conditions, with Sarcoma,Soft Tissue appearing as the primary indexed condition, and to 1 intervention - of which SBRT is the first listed.

NCT01949506 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT01949506 about?

NCT01949506 is a clinical study titled "(SBRT) and (ART) for Pulmonary Metastases From Soft Tissue Sarcomas". This is a prospective study to document the local control rates with SBRT specifically for pulmonary metastases from soft tissue sarcoma. This study will prospectively document acute and late toxicity, quality of life (QoL), tumor control, and survival.

What is the current status of trial NCT01949506?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2013-09-24. Estimated completion is 2019-10-04.

What conditions does trial NCT01949506 study?

This clinical trial studies the following conditions: Sarcoma,Soft Tissue, Stage IV Adult Soft Tissue Sarcoma.

What interventions are being tested in trial NCT01949506?

The interventions under investigation include: SBRT (RADIATION).

Who is sponsoring clinical trial NCT01949506?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01949506 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sarcoma,Soft Tissue

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01949506's enrollment target sits among peer trials

9 9th of 12 higher than 3 of 12 other Sarcoma,Soft Tissue trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sarcoma,Soft Tissue trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT01949506, the US trial registry maintained by the National Library of Medicine. NCT01949506 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.